跳至主要内容
临床试验/NL-OMON22188
NL-OMON22188尚未招募不适用

Feasibility of using the Pap-smear as a screening device for the detection of endometrial and ovarian cancer

Radboud university medical center0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
150

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • Endometrial cancer: all patients presenting with preoperative diagnosis of endometrial cancer (via pipelle endometrial biopsy or dilatation and curettage).
  • Ovarian cancer: all patients scheduled for surgery for suspected ovarian cancer (RMI>200, ascites).

排除标准

  • Patients who received pelvic radiation in the past and patients with ovarian cancer who do not have a uterus will not be able to participate in this study.

研究者

相似试验